(Q36871706)

16 August 2017

1 reference

title

Multipotent mesenchymal stromal cells and immune tolerance (English)

1 reference

16 August 2017

2

Farida Djouad

1 reference

16 August 2017

Danièle Noël

1

1 reference

16 August 2017

Carine Bouffi

series ordinal

3

1 reference

16 August 2017

Dominique Mrugala

series ordinal

4

1 reference

16 August 2017

Christian Jorgensen

series ordinal

5

1 reference

16 August 2017

language of work or name

1 reference

1 July 2007

1 reference

16 August 2017

1 reference

16 August 2017

volume

48

1 reference

16 August 2017

issue

7

1 reference

16 August 2017

page(s)

1283-1289

1 reference

Mesenchymal stem cells: clinical applications and biological characterization.

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F10428190701361869

Marrow-isolated adult multilineage inducible (MIAMI) cells, a unique population of postnatal young and old human cells with extensive expansion and differentiation potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701361869

RETRACTED: Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701361869

Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701361869

The biology and application of human bone marrow stromal cell precursors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701361869

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701361869

Allogeneic hematopoietic stem cell transplantation: state of the art and new perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701361869

Fibroblast growth factor and ex vivo expansion of hematopoietic progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701361869

Cardiomyocytes can be generated from marrow stromal cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701361869

Plasticity and therapeutic potential of mesenchymal stem cells in the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701361869

Functional neuronal differentiation of bone marrow-derived mesenchymal stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701361869

Mesenchymal stem cells: future source for reparative medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701361869

Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701361869

Transcriptional profiles discriminate bone marrow-derived and synovium-derived mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701361869

Veto-Like Activity of Mesenchymal Stem Cells: Functional Discrimination Between Cellular Responses to Alloantigens and Recall Antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701361869

Antigen-presenting property of mesenchymal stem cells occurs during a narrow window at low levels of interferon-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701361869

Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701361869

Human mesenchymal stem cells modulate B-cell functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701361869

Human mesenchymal stem cells modulate allogeneic immune cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701361869

Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701361869

Human mesenchymal stem cells support unrelated donor hematopoietic stem cells and suppress T-cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701361869

Immune modulation by mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701361869

Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701361869

Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701361869

Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701361869

Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701361869

Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701361869

Mesenchymal stem cells induce apoptosis of activated T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701361869

Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701361869

Mesenchymal stem cells are capable of homing to the bone marrow of non-human primates following systemic infusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701361869

Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701361869

Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701361869

Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701361869

Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701361869

10.1080/10428190701361869

21 January 2018

Identifiers

DOI

1 reference

16 August 2017

1 reference